Rheumatology Unit, Department of Neurosciences, Psychology, Drug Research and Child Health, Meyer Children's Hospital, University of Florence, Florence, Italy.
Department of Pediatrics, Kawasaki Disease Research Center, Rady Children's Hospital, University of California, San Diego, San Diego, CA, United States.
Front Immunol. 2018 Dec 14;9:2974. doi: 10.3389/fimmu.2018.02974. eCollection 2018.
The exact classification of Kawasaki disease (KD) has been debated. Infectious disease specialists have claimed it as an infection with a classic immune responses to an as yet unidentified pathogen that localizes to the coronary arteries. Others have favored an autoreactive hypothesis that KD is triggered by an antigen that shares homology with structures in the vascular wall, and molecular mimicry resulting in an immune response directed to that tissue. Rheumatologists have classified it as a systemic vasculitis, while some immunologists have stressed the robust nature of the innate immune response that causes both systemic inflammation as well as damage to the coronary arterial wall and questioned whether KD falls within the spectrum of autoinflammatory diseases. This review will describe the evidences available up to now regarding these hypotheses.
川崎病(KD)的具体分类一直存在争议。传染病专家认为它是一种感染,其经典的免疫反应针对一种尚未确定的病原体,这种病原体定位于冠状动脉。另一些人则倾向于自身免疫假说,即 KD 是由与血管壁结构同源的抗原触发的,导致针对该组织的免疫反应的分子模拟。风湿病学家将其归类为系统性血管炎,而一些免疫学家则强调引起全身炎症以及冠状动脉壁损伤的固有免疫反应的强大性质,并质疑 KD 是否属于自身炎症性疾病的范畴。本综述将描述迄今为止关于这些假说的证据。